Mesenchymal Stem Cells: Paving the Way for Myeloma Onset?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Medyouf H, Mossner M, Jann J, Nolte F, Raffel S, Herrmann C
. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014; 14(6):824-37.
DOI: 10.1016/j.stem.2014.02.014.
View
2.
Bernstein Z, Kim E, Raje N
. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells. 2022; 11(15).
PMC: 9367243.
DOI: 10.3390/cells11152308.
View
3.
Batsivari A, Haltalli M, Passaro D, Pospori C, Lo Celso C, Bonnet D
. Dynamic responses of the haematopoietic stem cell niche to diverse stresses. Nat Cell Biol. 2020; 22(1):7-17.
DOI: 10.1038/s41556-019-0444-9.
View
4.
Bogun L, Koch A, Scherer B, Fenk R, Maus U, Bormann F
. Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Adv. 2024; 8(10):2575-2588.
PMC: 11145751.
DOI: 10.1182/bloodadvances.2023011632.
View
5.
Corre J, Mahtouk K, Attal M, Gadelorge M, Huynh A, Fleury-Cappellesso S
. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia. 2007; 21(5):1079-88.
PMC: 2346535.
DOI: 10.1038/sj.leu.2404621.
View